Dear bobjones..
It's only human that after the huge shock of the AdComm circus the CEO might be in shock...I know I was in shock. I have done a lot of research into AMRN's situation, and I could not answer the question if there has ever been a case where the FDA reneged on an SPA..And at the time the questioned was raised, there was no one on this board that knew the answer.
I have invested in a lot of biotechs..It is not a game for sissies. When the FDA dings the company or the trial fails it is always the head of the CEO the mob wants. Dealing with the FDA requires the skill of a lion tamer. You have to keep the beast in sight at all times and try not to do anything that angers it. What more can the company, the CEO do except comply with the FDA's requests, the FDA admits AMRN has met its wishes..What else do you want the guy to do?..Seriously make a positive suggestion.
":>) JL